Recognized as a national forum for the German biotechnology industry sector, the German Biotechnology Days (DBT) serves as a convergence point for entrepreneurs, scientists, and stakeholders from political, funding, and administrative spheres. Over two days, the program will spotlight the wide-ranging applications and potential of biotechnology, spanning from health research to the bioeconomy.

The DBT 2024 agenda features two plenary sessions and a multitude of symposia and breakout sessions, encompassing the full spectrum of biotechnology topics.

Dr. Birgit Kerber will moderate the symposium session titled “IP, Market Value, and Start-ups” alongside Thomas Hanke from Evotech.

Download the event programme here.

Register here.

The DBT is a collaborative effort between BIO Deutschland and the Council of German BioRegions.